Related Experiment Video

Updated: Aug 14, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Evolving role of pegylated interferons in metastatic renal cell carcinoma

Toni K Choueiri1, Thomas E Hutson, Ronald M Bukowski

  • 1Department of Internal Medicine, The Cleveland Clinic Foundation, OH 44195, USA.

Expert Review of Anticancer Therapy
|December 23, 2003
PubMed

Insights

Pegylated Interferon (IFN)-alpha offers improved pharmacokinetics and efficacy in cancer treatment. Ongoing studies explore its potential in metastatic renal cell carcinoma and other malignancies.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Interferon (IFN)-alpha exhibits antitumor activity against various cancers, including metastatic renal cell carcinoma.
  • Pegylation enhances drug pharmacokinetics, prolonging half-life and potentially improving efficacy.
  • Pegylated IFN-alpha has shown promise in treating chronic hepatitis C and chronic myelogenous leukemia.

Purpose of the Study:

  • To review the role and ongoing evaluation of pegylated Interferon (IFN)-alpha in cancer therapy.
  • To highlight the pharmacokinetic and efficacy benefits of pegylation in biologic drugs.

Main Methods:

  • Review of existing literature on pegylated Interferon (IFN)-alpha (PEGASYS and PEG Intron).
  • Analysis of data from registrational studies in hepatitis C.
  • Summary of ongoing studies in metastatic renal cell carcinoma and other cancers.

Main Results:

  • Pegylated IFN-alpha demonstrated greater efficacy with similar safety profiles compared to nonpegylated forms in hepatitis C treatment.
  • Pegylation leads to prolonged half-life and increased area under the curve.
  • Studies in metastatic renal cell carcinoma and other cancers are currently in progress.

Conclusions:

  • Pegylated Interferon (IFN)-alpha offers an advantageous therapeutic option due to improved pharmacokinetics and efficacy.
  • Further research is warranted to establish the full potential of pegylated IFN-alpha in treating metastatic renal cell carcinoma and other malignancies.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...